Advances in the research of β-ketoacyl-ACP synthase III (FabH) inhibitors

Current Medicinal Chemistry

Volumn 19, Issue 8, 2012, Pages 1225-1237

  Zhang, H J ^a   Li, Z L ^a   Zhu, H L ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

1,2 Dithiole 3 (thi)ones derivatives; Alkyl CoA disulfides; Alkylsulfonyl derivatives; Anti bacterial agents; Benzoylaminobenzoic acid derivatives; Cerulenin derivatives; FabH; FabH inhibitors; Fatty acid synthase (FAS); Indole derivatives; Thiazolidine 2 one 1,1 dioxide derivatives; Thiolactomycin derivatives

Indexed keywords

3 OXOACYL ACYL CARRIER PROTEIN SYNTHASE; 3 OXOACYL ACYL CARRIER PROTEIN SYNTHASE III INHIBITOR; AMINOBENZOIC ACID DERIVATIVE; CERULENIN; CERULENIN DERIVATIVE; ENZYME INHIBITOR; FATTY ACID; INDOLE DERIVATIVE; SB 2418011; SULFONE DERIVATIVE; THIAZOLIDINE DERIVATIVE; THIOLACTOMYCIN; THIOLACTOMYCIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME STRUCTURE; FATTY ACID SYNTHESIS; NONHUMAN; REVIEW;

3-OXOACYL-(ACYL-CARRIER-PROTEIN) SYNTHASE; ANIMALS; ANTI-BACTERIAL AGENTS; ENZYME INHIBITORS; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE;

EID: 84863230265     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712799320484     Document Type: Review

References (78)

1. Volker, C.; Brown, J.R. Bioinformatics and the discovery of novel antimicrobial targets. Curr. Drug Targets Infect. Disord, 2002, 2, 279-290 (Pubitemid 35439441)
2. Revill, W. P.; Bibb, M. J.; Scheu, A. K.; Kieser, H. J.; Hopwood, D. A. Betaketoacyl acyl carrier protein synthase III (FabH) is essential for fatty acid biosynthesis in Streptomyces coelicolor A3(2). J. Bacteriol, 2001, 183, 3526- 3530
3. Heath, R. J.; White, S. W.; Rock, C. O. Inhibitors of fatty acid synthesis as antimicrobial chemotherapeutics. Microbiol. Biothchnol, 2002, 58, 695-703
4. Lai, C. Y.; Cronan, J. E. β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) Is Essential for Bacterial Fatty Acid Synthesis. J. Biol. Chem, 2003, 278, 51494-51503 (Pubitemid 38020391)
5. Li, Y.; Florova, G.; Reynolds, K. A. KA (2005). Ŝanĝo de la grasacidoprofilo de Streptomyces koelikolor de anstataǔaĵo de la inicenzimo 3-ketoacil acila aviad-kompanioproteinosintase III (FabH). J. Bacteriol, 2005, 187, 3795-3799
6. Wakil, S. J. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry, 1989, 28, 4523-4530 (Pubitemid 19151020)
7. Joshi, A. K.; Witkowski, A.; Smith, S. Mapping of functional interactions between domains of the animal fatty acid synthase by mutant complementation in vitro. Biochemistry, 1997, 36, 2316-2322 (Pubitemid 27104726)
8. Schweizer, E.; Hofmann, J. Microbial Type I Fatty Acid Synthases (FAS): Major Players in a Network of Cellular FAS Systems. Microbiol. Mol. Biol. Rev, 2004, 68, 501-517 (Pubitemid 39238280)
9. Clough, R. C.; Matthis, M.; Barnum, S. R.; Jaworski, J. G. Purification and characterization of 3-ketoacyl-acyl camer protein synthase III from spinach. J. Biol. Chem, 1992, 267, 20992-20998
10. Rock, C. O.; Cronan, J. E. Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis. Biochim. Biophys. Acta, 1996, 1302, 1-16 (Pubitemid 26267038)
11. Surolia, N.; Surolia, A. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat. Med, 2001, 7, 167-173 (Pubitemid 32148482)
12. Cronan, J. E. Biosynthesis of membrane lipids. American Society for Microbiology, 1996, 2, 612-636
13. Rock, C. O.; Jackowski, S.; Cronan, J. E. Lipid metabolism in prokaryotes. Biochemistry of lipids, lipoproteins and membranes, 1996, 31, 35-74
14. Wang, J.; Soisson, S. M.; Young, K.; Shoop, W.; Kodali, S.; Galgoci, A.; Painter, R.; Parthasarathy, G.; Tang, Y. S.; Cummings, R. et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature, 2006, 441, 358-361 (Pubitemid 44050201)
15. Heath, R. J.; White, S. W.; Rock, C. O. Lipid biosynthesis as a target for antibacterial agents. Prong. Lipid Res, 2001, 40, 467-497 (Pubitemid 32929968)
16. Prigge, S. T.; He, X.; Gerena, L.; Waters, N. C.; Reynolds, K. A. The initiating steps of a type II fatty acid synthase in Plasmodium falciparum are catalyzed by pfACP, pfMCAT, and pfKASIII. Biochemistry, 2003, 42, 1160-1169 (Pubitemid 36159551)
17. Ali, A.; Seung, J. C. A combined approach of docking and 3D QSAR study of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Bioorg. Med. Chem, 2006, 14, 1474-1482
18. Puupponen-Pimia, R.; Nohynek, L.; Meier, C.; Kahkonen, M.; Heinonen, M. Antimicrobial properties of phenolic compounds from berries. J. Appl. Microbiol, 2001, 4, 494-507 (Pubitemid 32291248)
19. Lu, J. Z.; Lee, P. J.; Waters, N. C.; Prigge, S. T. Fatty Acid synthesis as a target for antimalarial drug discovery. Comb. Chem. High Throughput Screening, 2005, 8, 15-26
20. Lu, Y. J.; Zhang, Y. M.; Rock, C. O. Product diversity and regulation of type II fatty acid synthases. Bochem. Cell Biol, 2004, 82, 145-155 (Pubitemid 38580880)
21. Marrakchi, H.; Zhang, Y. M.; Rock, C. O. Mechanistic diversity and regulation of Type II fatty acid synthesis. Bochem. Soc. Trans. 2002, 30, 1050-1055 (Pubitemid 36002404)
22. White, S. W.; Zheng, J.; Zhang, Y. M.; Rock, C. O. The structural biology of type II fatty acid biosynthesis. Annu. Rev. Biochem, 2005, 74, 791-831 (Pubitemid 40995524)
23. Veyron-Churlet, R.; Guerrini, O.; Mourey, L.; Daffe, M.; Zerbib, D. Proteinprotein interactions within the Fatty Acid Synthase-II system of Mycobacterium tuberculosis are essential for mycobacterial viability. Mol. Microbiol, 2004, 54, 1161-1172 (Pubitemid 39578262)
24. Khandekar, S. S.; Daines, R. A.; Lonsdale, J. T. Bacterial beta-ketoacyl-acyl carrier protein synthases as targets for antibacterial agents. Curr. Protein Pept. Sci, 2003, 4, 21-29 (Pubitemid 36138691)
25. Heath, R. J.; Rock, C. O. Inhibition of β-ketoacyl-acyl carrier protein synthase III (FabH) by acyl-acyl carrier protein in Escherichia coli. J. Biol. Chem, 1996, 3, 10996-11000 (Pubitemid 26145842)
26. Heath, R. J.; Rock, C. O. The Claisen condensation in biology. Nat. Prod. Rep, 2002, 19, 581-596 (Pubitemid 35259019)
27. Lee, J. Y.; Jeong, K. W.; Lee, J. U.; Kang, D.; Kim. Y. Novel E. coli β-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics. Bioorg. Med. Chem, 2009, 17, 1506-1513
28. Qiu, X.; Janson, C. A.; Konstantinidis, A. K.; Nwagwu, S.; Silverman, C.; Smith, W. W.; Khandekar, S.; Lonsdale, J.; Abdel-Meguid, S.S. Crystal Structure of β-Ketoacyl-Acyl Carrier Protein Synthase III: A key condensing enzyme in bacterial fatty acid biosynthesis. J. Biol. Chem, 1999, 274, 36465-36471
29. Davies, C.; Heath, R. J.; White, S. W.; Rock, C. O. The 1.8 Å crystal structure and active-site architecture of β-ketoacyl-acyl carrier protein synthase III (FabH) from Escherichia coli. Structure, 2000, 8, 185-195 (Pubitemid 30097364)
30. Qiu, X.; Janson, C. A.; Smith, W. W.; Head, M.; Lonsdale, J.; Konstantinidis, A.K. Refined structures of beta-ketoacyl-acyl carrier protein synthase III. J. Mol. Biol, 2001, 307, 341-356 (Pubitemid 33029986)
31. Huang, W. J.; Jia, J.; Edwards, P.; Dehesh, K.; Schneider, G.; Lindqvist, Y. Crystal structure of β-ketoacyl-acyl carrier protein synthase II from E.coli reveals the molecular architecture of condensing enzymes. EMBO J, 1998, 17, 1183-1191 (Pubitemid 28105497)
32. Moche, M.; Schneider, G.; Edwards, P.; Dehesh, K.; Lindqvist, Y. Structure of the complex between the antibiotic cerulenin and its target, beta-Ketoacyl-ACP synthase. J. Biol. Chem, 1999, 274, 6031-6034 (Pubitemid 29111003)
33. Mathieu, M.; Zeelen, J. P.; Pauptit, R. A.; Erdmann, R.; Kunau, W. H.; Wierenga, R. K. The 2.8 A crystal structure of peroxisomal 3-ketoacyl-CoA thiolase of Saccharomyces cerevisiae: a five-layered alpha beta alpha beta alpha structure constructed from two core domains of identical topology. Structure, 1994, 2, 797-808
34. Khandekar, S. S.; Konstantinidis, A. K.; Silverman, C.; Janson, C. A.; McNulty, D. E.; Nwagwu, S.; Van Aller, G. S.; Doyle, M. L.; Kane, J. F.; Qiu, X.; Lonsdale, J. Expression, purification, and crystallization of the Escherichia coli selenomethionyl beta-ketoacyl-acyl carrier protein synthase III. Biochem. Biophys. Res. Commun, 2000, 270, 100-107 (Pubitemid 30440399)
35. Qiu, X.; Choudhry, A. E.; Janson, C. A.; Grooms, M.; Daines, R. A.; Lonsdale, J. T.; Khandekar, S. S. Crystal structure and substrate specificity of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus. Protein Sci, 2005, 14, 2087-2094 (Pubitemid 41132374)
36. Han, L.; Lobo, S.; Reynolds, K. A. Physiology and metabolism: Characterization of β-Ketoacyl-Acyl Carrier Protein Synthase III from Streptomyces glaucescens and Its Role in Initiation of Fatty Acid Biosynthesis. J. Bacteriol, 1998, 180, 4481-4486 (Pubitemid 28405572)
37. Choi, K. H.; Kremer, L.; Besra, G. S.; Rock, C. O. Identification and substrate specificity of β-ketoacyl (acyl carrier protein) synthase III (mtFabH) from Mycobacterium tuberculosis. J. Biol. Chem, 2000, 275, 28201-28207
38. Choi, K. H.; Heath, R. J.; Rock, C. O. β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) Is a Determining Factor in Branched-Chain Fatty Acid Biosynthesis. J. Bacteriol, 2000, 182, 365-370 (Pubitemid 30030119)
39. Khandekar, S. S.; Gentry, D. R.; Van Aller, G. S.; Warren, P.; Xiang, H.; Silverman, C.; Doyle, M. L.; Chambers, P. A.; Konstantinidis, A. K.; Brandt, M. et al. Identification, Substrate Specificity, and Inhibition of the Streptococcus pneumoniae β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH)*. J. Biol. Chem, 2001, 276, 30024-30030
40. He, X.; Reynolds, K. A. Purification, Characterization, and Identification of Novel Inhibitors of the β-Ketoacyl-Acyl Carrier Protein Synthase III (FabH) from Staphylococcus aureus. Antimicrob. Agents Chemother, 2002, 46, 1310-1318 (Pubitemid 34415307)
41. Tsay, J. T.; Oh, W.; Larson, T. J.; Jackowski, S.; Rock, C. O. Isolation and characterization of the β-ketoacyl-acyl carrier protein synthase III gene (fabH) from Escherichia coli K-12. J. Biol. Chem, 1992, 267, 6807-6814
42. Kauppinen, S.; Siggaard-Anderson, M.; Wettstein-Knowles, P. beta-Ketoacyl-ACP synthase I of Escherichia coli: nucleotide sequence of the fabB gene and identification of the cerulenin binding residue.Carlsberg. Res. Commun, 1988, 53, 357-370
43. Currier, S. F.; Mautner, H. G. Evidence for a thiol reagent inhibiting choline acetyltransferase by reacting with the thiol group of coenzyme A forming a potent ingibitor. Biophys. Res. Commun, 1976, 69, 431-436
44. Currier, S. F.; Mautner, H. G. Interaction of analogues of coenzyme A with choline acetyltransferase. Biochemistry, 1977, 16, 1944-1948 (Pubitemid 8088597)
45. Rossier, J. Acetyl-coenzyme A and coenzyme A analogues. Their effects on rat brain choline acetyltransferase. Biochem. J, 1977, 165, 321-326 (Pubitemid 8154792)
46. Mautner, H. G.; Currier, S. F. Studies on the mechanism of action of choline acetyltransferase. Adv. Behav. Biol, 1978, 24, 197-206
47. Weber, B. H.; Hariri, M.; Martin, D.; Driskell, W. J. Enzymic properties of choline acetyltransferase from heads of Drosophila melanogster. J. Neurochem, 1979, 32, 1597-1598
48. Mautner, H. G.; Merrill, R. E.; Currier, S. F.; Harvey, G. Interaction of aromatic dyes with the coenzyme A binding site of choline acetyltransferase. J. Med. Chem, 1981, 24, 1534-1537 (Pubitemid 12164096)
49. Mamoun, M.; Aihamadsheh, F. M.; Andrey, A. K.; Sarbjot, S.; Wright, H. T.; Neel, S.; Galina, F.; Reynolds, K. A. Alkyl-CoA Disulfides as Inhibitors and Mechanistic Probes for FabH Enzymes. Chemistry and Biology, 2007, 14, 513-524 (Pubitemid 46765149)
50. Scarsdale, J. N.; Kazanina, G.; He, X.; Reynolds, K. A.; Wright, H. T. Crystal structure of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III. J. Biol. Chem, 2001, 276, 20516-20522
51. Brown, A. K.; Sridharan, S.; Kremer, L.; Lindenberg, S.; Dover, L. G.; Sacchettini, J. C.; Besra, G. S. Probing the Mechanism of the Mycobacterium tuberculosis {beta}-Ketoacyl-Acyl Carrier Protein Synthase III mtFabH: FACTORS INFLUENCING CATALYSIS AND SUBSTRATE SPECIFICITY. J. Biol. Chem, 2005, 280, 32539-32547 (Pubitemid 41361868)
52. Jackowski, S.; Murphy, C. M.; Cronan, J. E.; Rock, C. O. Acetoacetyl-acyl carrier protein synthase. A target for the antibiotic thiolactomycin. J. Biol. Chem, 1989, 264, 7624-7629 (Pubitemid 19119182)
53. Musayev, F.; Sachdeva, S.; Scaradale, J. N.; Reynolds, K. A.; Wright, H. T. Crystal Structure of a Substrate Complex of Mycobacterium tuberculosis β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) with Lauroyl-coenzyme A. J. Mol. Biol, 2005, 346, 1313-1321 (Pubitemid 40248831)
54. Miyakawa, S.; Suzuki, K.; Noto, T.; Harada, Y.; Okazaki, H. Thiolactomycin, a new antibiotic. IV. Biological properties and chemotherapeutic activity in mice. J Antibiot, 1982, 35, 411-419
55. Price, A. C.; Choi, K. H.; Heath, R. J.; Li, Z. Rock, C. O.; White, S. W. Inhibition of β-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. J. Biol. Chem, 2001, 276, 6551-6559
56. Jones, A. L.; Herbert, D.; Rutter, A. J.; Dancer, J. E.; Harwood, J. L. Beta-ketoacyl- acyl carrier protein synthase III from pea (Pisum sativum L.): properties, inhibition by a novel thiolactomycin analogue and isolation of a cDNA clone encoding the enzyme. Biochem J, 2000, 347, 205-209
57. Kremer, L.; Douglas, J. D.; Baulard, A. R. et al. Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis. J Biol Chem, 2000, 275, 16857-16864 (Pubitemid 30398921)
58. Douglas, J. D.; Senior, S. J.; Morehouse, C.; Phetsukiri, B.; Campbell, I. B.; Besra, G. S.; Minnikin, D. E. Analogues of thiolactomycin: potential drugs with enhanced anti-mycobacterial activity. Microbiology, 2002, 148: 3101-3109 (Pubitemid 35243709)
59. McFadden, J. M.; Frehywot, G. L.; Townsend, C. A. A Flexible Route to (5R)-Thiolactomycin, a Naturally-Occurring Inhibitor of Fatty Acid Synthesis. Org. Lett, 2002, 4, 3859-3862
60. Sakya, S. M.; Suarez-Contreras, M.; Dirlam, J. P.; O'Connell, T. N.; Hayashi, S. F.; Santoro, S. L.; Kamicker, B. J.; George, D. M.; Ziegler, C. B. Synthesis and structure-activity relationships of thiotetronic acid analogues of thiolactomycin. Bioorg. Med. Chem. Lett, 2001, 11: 2751-2754 (Pubitemid 32925309)
61. Xin, H.; Anne, M. R.; Umesh, R.; Desai, G. E.; et al. 1,2-Dithiole-3-Ones as Potent Inhibitors of the Bacterial 3-Ketoacyl Acyl Carrier Protein Synthase III (FabH). Antimicrobial Agents and Chemotherapy, 2004, 48, 3093-3102
62. Carey, K. A.; Kensler, T. W.; Fishbein, J. C. Kinetic constraints for the thiolysis of 4-methyl-5-(pyrazin-2-yl)-1,2-dithiole-3-thione (oltipraz) and related dithiole-3-thiones in aqueous solution. Chem. Res. Toxicol, 2001, 14, 939-945 (Pubitemid 32800148)
63. Pedersen, C. T. 1,2-Dithiole-3-thiones and 1,2-dithiol-3-ones. Sulfur Rep, 1995, 16, 173-221
64. Daines, R. A.; Pendrak, I.; Sham, K. et al. First X-ray cocrystal structure of a bacterial FabH condensing enzyme and a small molecule inhibitor achieved using rational design and homology modeling. J. Med. Chem, 2003, 46, 5-8 (Pubitemid 36043780)
65. Omura, S.; Katagiri, M.; Nakagawa, A.; Sano, Y.; Nomura, S. Studies on cerulenin. V. Structure of cerulenin. J Antibiot, 1967, 20, 349-354
66. D'Agnolo, G.; Rosenfeld, I. S.; Awaya, J.; Omura, S.; Vagelos, P. R. Inhibition of fatty acid synthesis by the antibiotic cerulenin. Specific inactivation of beta-ketoacyl-acyl carrier protein synthetase. Biochim Biophys Acta, 1973, 326, 155-156
67. Nomura, S.; Horiuchi, T.; Omura, S.; Hata, T. The action mechanism of cerulenin. I. Effect of cerulenin on sterol and fatty acid biosynthesis in yeast. J. Biochem, 1972, 71, 783-796
68. Kuhajda, F. P.; Pizer, E. S.; Li, J. N.; Mani, N. S.; Frehywot, G. L.; Townsend, C. A. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci, 2000, 97, 3450-3454 (Pubitemid 30183323)
69. Loftus, T. M.; Jaworsky, D. E.; Frehywot, G. L. et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science, 2000, 288, 2379-2381
70. Tsay, J. T.; Rock, C. O.; Jackowski, S. Overproduction of beta-ketoacyl-acyl carrier protein synthase I imparts thiolactomycin resistance to Escherichia coli K-12. J Bacteriol, 1992, 174, 508-513
71. Jackowski, S.; Rock, C. O. Acetoacetyl-acyl carrier protein synthase, a potential regulator of fatty acid biosynthesis in bacteria. J. Biol. Chem, 1987, 262, 7927-7931
72. Schujman, G. E.; Choi, K. H.; Altabe, S.; Rock, C. O.; Mendoza, D. Response of Bacillus subtilis to Cerulenin and Acquisition of Resistance. J. Bacteriol, 2001, 183, 3032-3040 (Pubitemid 32433519)
73. Nie, Z.; Perretta, C.; Lu, J.; Su, Y.; Margosiak, S. et al. Structure-Based Design, Synthesis, and Study of Potent Inhibitors of β-Ketoacyl-acyl Carrier Protein Synthase III as Potential Antimicrobial Agents. J. Med. Chem, 2005, 48, 1596-1609 (Pubitemid 40364566)
74. Jones, P. B.; Parrish, N. M.; Houston, T. A. et al. A new class of antituberculosis agents. J. Med. Chem, 2000, 43, 3304-3314
75. Dolak, L. A.; Castle, T. M.; Truesdell, S. E.; Sebek, O. K. Isolation and structure of antibiotic U-68,204, a new thiolactone. J. Antibiot, 1986, 39, 26-31 (Pubitemid 16174633)
76. Nishida, I.; Kawaguchi, A.; Yamada, M. Effect of thiolactomycin on the individual enzymes of the fatty acid synthase system in Escherichia coli. J. Biochem, 1986, 99, 1447-1454 (Pubitemid 16033515)
77. 2 from 3-benzylthiazolidin-2-one 1,1-dioxides to give 2-phenylthiazolines and thiazoles. Tetrahedron Lett, 1994, 33, 6143-6146
78. Alhamadsheh, M. M.; Wsters, N. C.; Huddler, D. P. et al. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents. Bioorg. Med. Chem. Lett, 2007, 17, 879-883